BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Evelo Biosciences Expands Executive Leadership Team

  Evelo Biosciences today announced the expansion of its executive leadership team with the appointment of Duncan McHale, M.D., Ph.D. as CMO and Michael Garcia-Webb, Ph.D. as head of people and operational excellence.

  February 8, 2018

   · 

  3 min read
• Drug Development

  Bonti Announces Dosing of the First Patient in the SHINE-1 Phase II Clinical Study Evaluating EB-001 for Scar Reduction

  Bonti announced the initiation of the SHINE (Scar Healing Improvement with Neurotoxin E) clinical program, aimed at scar reduction using its novel neurotoxin.

  February 8, 2018

   · 

  4 min read
• Business

  Q Biomed Signs Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma

  Q Biomed is pleased to announce an exclusive option agreement with Washington University in St. Louis.

  February 8, 2018

   · 

  4 min read
• Pharm Country

  Celgene Announces Offering of Senior Unsecured Notes Under a Shelf Registration Statement on Form S-3

  The interest rate, the maturity dates and other key terms of the offering are to be determined at the time of pricing.

  February 8, 2018

   · 

  3 min read
• Drug Development

  pSivida’s Second Phase III Study for Durasert Three-Year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months

  The study involved 153 patients with posterior segment uveitis.

  February 8, 2018

   · 

  7 min read
• Business

  Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results

  Net revenue increased 2.5% to $182.3 million compared to $177.9 million in the same quarter last year.

  February 8, 2018

   · 

  17 min read
• Drug Development

  ArmaGen’s AGT-181 Demonstrates Neurocognitive Benefit in Children With Severe MPS I

  On a somatic level, AGT-181 stabilized urinary glycosaminoglycans, reduced liver and spleen volume including in patients previously exposed to laronidase, and further improved shoulder range of motion.

  February 8, 2018

   · 

  7 min read
• Biotech Beach

  GenomeDx Biosciences’ Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at 2018 Genitourinary Cancers Symposium

  The 2018 GU Cancers Symposium is the premier scientific and educational meeting .

  February 8, 2018

   · 

  6 min read
• Business

  IMRIS Reports Continued Strong Growth in 2017

  Due to continued business growth, IMRIS has expanded the organization incrementally with the addition of more than 25 new personnel in the past 12 months.

  February 8, 2018

   · 

  3 min read
• Biotech Beach

  MediciNova Announces Proposed Underwritten Public Offering of Common Stock

  The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

  February 8, 2018

   · 

  6 min read